Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 617

1.

Military Telehealth: A Model For Delivering Expertise To The Point Of Need In Austere And Operational Environments.

Pamplin JC, Davis KL, Mbuthia J, Cain S, Hipp SJ, Yourk DJ, Colombo CJ, Poropatich R.

Health Aff (Millwood). 2019 Aug;38(8):1386-1392. doi: 10.1377/hlthaff.2019.00273.

PMID:
31381391
2.

Begging behavior as an honest signal of need and parent-offspring association during the postfledging dependency period.

Davis KL, Karpanty SM, Spendelow JA, Cohen JB, Althouse MA, Parsons KC, Luttazi CF.

Ecol Evol. 2019 Jun 17;9(13):7497-7508. doi: 10.1002/ece3.5279. eCollection 2019 Jul.

3.

Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice.

Blonde L, Brunton SA, Chava P, Zhou R, Meyers J, Davis KL, Dalal MR, DiGenio A.

Diabetes Spectr. 2019 May;32(2):93-103. doi: 10.2337/ds17-0082.

PMID:
31168279
4.

Treatment patterns and characteristics of patients with migraine in Japan: A retrospective analysis of health insurance claims data.

Meyers JL, Davis KL, Lenz RA, Sakai F, Xue F.

Cephalalgia. 2019 Jun 1:333102419851855. doi: 10.1177/0333102419851855. [Epub ahead of print]

PMID:
31154807
5.

Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States.

Kabadi SM, Goyal RK, Nagar SP, Kaye JA, Davis KL.

Cancer Med. 2019 Jul;8(8):3803-3810. doi: 10.1002/cam4.2268. Epub 2019 May 29.

6.

Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR+/HER2- Advanced Breast Cancer Enrolled in an Expanded Access Program.

Brufsky A, Mitra D, Davis KL, Nagar SP, McRoy L, Cotter MJ, Stearns V.

Clin Breast Cancer. 2019 Apr 18. pii: S1526-8209(18)30809-7. doi: 10.1016/j.clbc.2019.04.005. [Epub ahead of print]

7.

Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2- metastatic breast cancer.

Goyal RK, Carter GC, Nagar SP, Smyth EN, Price GL, Huang YJ, Li L, Davis KL, Kaye JA.

Curr Med Res Opin. 2019 Jun 12:1-12. doi: 10.1080/03007995.2019.1615422. [Epub ahead of print]

PMID:
31060392
8.

Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia.

Diaz-Flores E, Comeaux EQ, Kim KL, Melnik E, Beckman K, Davis KL, Wu K, Akutagawa J, Bridges O, Marino R, Wohlfeil M, Braun BS, Mullighan CG, Loh ML.

Cancer Res. 2019 May 1;79(9):2339-2351. doi: 10.1158/0008-5472.CAN-18-0236. Epub 2019 Mar 12.

PMID:
30862722
9.

Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France.

Lin HM, Davis KL, Kaye JA, Luptakova K, Nagar SP, Mohty M.

Adv Hematol. 2019 Jan 29;2019:4625787. doi: 10.1155/2019/4625787. eCollection 2019.

10.

Whale carcass leachate plumes in beach groundwater: A potential shark attractant to the surf?

Tucker JP, Santos IR, Davis KL, Butcher PA.

Mar Pollut Bull. 2019 Mar;140:219-226. doi: 10.1016/j.marpolbul.2019.01.043. Epub 2019 Jan 28.

PMID:
30803637
11.

Repositioning Flubendazole for Spinal Cord Injury.

Yu CG, Bondada V, Ghoshal S, Singh R, Pistilli CK, Dayaram K, Iqbal H, Sands M, Davis KL, Bondada S, Geddes JW.

J Neurotrauma. 2019 Sep 15;36(18):2618-2630. doi: 10.1089/neu.2018.6160. Epub 2019 Mar 15.

PMID:
30747048
12.

A novel platform for isotype-specific testing of autoantibodies.

Carter KL, Treurnicht A, Davis KL, Kumar RB, Feldman BJ.

PLoS One. 2019 Feb 7;14(2):e0211596. doi: 10.1371/journal.pone.0211596. eCollection 2019.

13.

Selected Principles of Pankseppian Affective Neuroscience.

Davis KL, Montag C.

Front Neurosci. 2019 Jan 17;12:1025. doi: 10.3389/fnins.2018.01025. eCollection 2018. Review.

14.

Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer.

Horn L, Bauml J, Forde PM, Davis KL, Myall NJ, Sasane M, Dalal A, Culver K, Wozniak AJ, Baik CS, Mutebi A, Zhang P, Wakelee HA, Johnson BE.

Lung Cancer. 2019 Feb;128:74-90. doi: 10.1016/j.lungcan.2018.12.003. Epub 2018 Dec 6.

PMID:
30642457
15.

Peer support opportunities across the cancer care continuum: a systematic scoping review of recent peer-reviewed literature.

Kowitt SD, Ellis KR, Carlisle V, Bhushan NL, Black KZ, Brodar K, Cranley NM, Davis KL, Eng E, Martin MY, McGuirt J, Sokol RL, Tang PY, Vines AI, Walker JS, Fisher EB.

Support Care Cancer. 2019 Jan;27(1):97-108. doi: 10.1007/s00520-018-4479-4. Epub 2018 Oct 6.

PMID:
30293093
16.

Single-cell mass cytometry and machine learning predict relapse in childhood leukemia.

Sarno J, Davis KL.

Mol Cell Oncol. 2018 Sep 12;5(5):e1472057. doi: 10.1080/23723556.2018.1472057. eCollection 2018.

17.

Perceptions of Rural African American Adults About the Role of Family in Understanding and Addressing Risk Factors for Cardiovascular Disease.

Ellis KR, Young TL, Carthron D, Simms M, McFarlin S, Davis KL, Dave G, Corbie-Smith G, Cené C.

Am J Health Promot. 2019 Jun;33(5):708-717. doi: 10.1177/0890117118799574. Epub 2018 Sep 24.

PMID:
30249119
18.

Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia.

Lin JK, Lerman BJ, Barnes JI, Boursiquot BC, Tan YJ, Robinson AQL, Davis KL, Owens DK, Goldhaber-Fiebert JD.

J Clin Oncol. 2018 Sep 13:JCO2018790642. doi: 10.1200/JCO.2018.79.0642. [Epub ahead of print]

PMID:
30212291
19.

SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia.

Sarno J, Savino AM, Buracchi C, Palmi C, Pinto S, Bugarin C, Jager A, Bresolin S, Barber RC, Silvestri D, Israeli S, Dyer MJS, Cazzaniga G, Nolan GP, Biondi A, Davis KL, Gaipa G.

Oncotarget. 2018 May 1;9(33):22872-22885. doi: 10.18632/oncotarget.25089. eCollection 2018 May 1.

20.

Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.

Blonde L, Raccah D, Lew E, Meyers J, Nikonova E, Ajmera M, Davis KL, Bertolini M, Guerci B.

Diabetes Ther. 2018 Jun;9(3):1169-1184. doi: 10.1007/s13300-018-0429-x. Epub 2018 Apr 19.

21.

False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy.

Laetsch TW, Maude SL, Milone MC, Davis KL, Krueger J, Cardenas AM, Eldjerou LK, Keir CH, Wood PA, Grupp SA.

Blood. 2018 Jun 7;131(23):2596-2598. doi: 10.1182/blood-2017-12-822940. Epub 2018 Apr 18. No abstract available.

22.

DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity.

Anchang B, Davis KL, Fienberg HG, Williamson BD, Bendall SC, Karacosta LG, Tibshirani R, Nolan GP, Plevritis SK.

Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4294-E4303. doi: 10.1073/pnas.1711365115. Epub 2018 Apr 13.

23.

The Initial Impact of Tele-Critical Care on the Surgical Services of a Community Military Hospital.

Van Gent JM, Davis KL, Henry N, Zander AL, Kuettel MA, Edson T, Nelson TJ, Tadlock MD.

Mil Med. 2018 Nov 1;183(11-12):e494-e499. doi: 10.1093/milmed/usy051.

PMID:
29635539
24.

Chirality Dependent Charge Transfer Rate in Oligopeptides.

Tassinari F, Jayarathna DR, Kantor-Uriel N, Davis KL, Varade V, Achim C, Naaman R.

Adv Mater. 2018 May;30(21):e1706423. doi: 10.1002/adma.201706423. Epub 2018 Apr 2.

PMID:
29611223
25.

Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib.

Davis KL, Kaye JA, Masters ET, Iyer S.

Curr Oncol. 2018 Feb;25(1):e40-e49. doi: 10.3747/co.25.3723. Epub 2018 Feb 28.

26.

Publisher Correction: High-resolution myogenic lineage mapping by single-cell mass cytometry.

Porpiglia E, Samusik N, Ho ATV, Cosgrove BD, Mai T, Davis KL, Jager A, Nolan GP, Bendall SC, Fantl WJ, Blau HM.

Nat Cell Biol. 2018 Aug;20(8):990. doi: 10.1038/s41556-018-0043-1.

PMID:
29507406
27.

Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse.

Good Z, Sarno J, Jager A, Samusik N, Aghaeepour N, Simonds EF, White L, Lacayo NJ, Fantl WJ, Fazio G, Gaipa G, Biondi A, Tibshirani R, Bendall SC, Nolan GP, Davis KL.

Nat Med. 2018 May;24(4):474-483. doi: 10.1038/nm.4505. Epub 2018 Mar 5.

28.

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine.

Imagawa H, Nagar SP, Montgomery W, Nakamura T, Sato M, Davis KL.

Neuropsychiatr Dis Treat. 2018 Feb 22;14:611-621. doi: 10.2147/NDT.S150261. eCollection 2018.

29.

Niclosamide suppresses acute myeloid leukemia cell proliferation through inhibition of CREB-dependent signaling pathways.

Chae HD, Cox N, Dahl GV, Lacayo NJ, Davis KL, Capolicchio S, Smith M, Sakamoto KM.

Oncotarget. 2017 Dec 31;9(4):4301-4317. doi: 10.18632/oncotarget.23794. eCollection 2018 Jan 12.

30.

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA, Grupp SA.

N Engl J Med. 2018 Feb 1;378(5):439-448. doi: 10.1056/NEJMoa1709866.

31.

Immunotherapy for acute lymphoblastic leukemia: from famine to feast.

Davis KL, Mackall CL.

Blood Adv. 2016 Dec 27;1(3):265-269. doi: 10.1182/bloodadvances.2016000034. eCollection 2016 Dec 27.

32.

Checkpoint inhibition in pediatric hematologic malignancies.

Davis KL, Agarwal AM, Verma AR.

Pediatr Hematol Oncol. 2017 Sep - Oct;34(6-7):379-394. doi: 10.1080/08880018.2017.1383542. Epub 2017 Nov 30. Review.

PMID:
29190182
33.

New developments in immunotherapy for pediatric solid tumors.

Schultz LM, Majzner R, Davis KL, Mackall C.

Curr Opin Pediatr. 2018 Feb;30(1):30-39. doi: 10.1097/MOP.0000000000000564. Review.

PMID:
29189429
34.

Identity and Diversity of Human Peripheral Th and T Regulatory Cells Defined by Single-Cell Mass Cytometry.

Kunicki MA, Amaya Hernandez LC, Davis KL, Bacchetta R, Roncarolo MG.

J Immunol. 2018 Jan 1;200(1):336-346. doi: 10.4049/jimmunol.1701025. Epub 2017 Nov 27.

35.

Ecological performance of construction materials subject to ocean climate change.

Davis KL, Coleman MA, Connell SD, Russell BD, Gillanders BM, Kelaher BP.

Mar Environ Res. 2017 Oct;131:177-182. doi: 10.1016/j.marenvres.2017.09.011. Epub 2017 Sep 20.

PMID:
28988853
36.

Effect of combination vaccines on completion and compliance of childhood vaccinations in the United States.

Kurosky SK, Davis KL, Krishnarajah G.

Hum Vaccin Immunother. 2017 Nov 2;13(11):2494-2502. doi: 10.1080/21645515.2017.1362515. Epub 2017 Sep 7.

37.

Examining the Benefits and Barriers of Instructional Gardening Programs to Increase Fruit and Vegetable Intake among Preschool-Age Children.

Davis KL, Brann LS.

J Environ Public Health. 2017;2017:2506864. doi: 10.1155/2017/2506864. Epub 2017 May 21.

38.

Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims.

Buck PO, Meyers JL, Gordon LD, Parikh R, Kurosky SK, Davis KL.

Epidemiol Infect. 2017 Jul;145(10):2109-2121. doi: 10.1017/S0950268817000887. Epub 2017 May 2.

39.

High-resolution myogenic lineage mapping by single-cell mass cytometry.

Porpiglia E, Samusik N, Ho ATV, Cosgrove BD, Mai T, Davis KL, Jager A, Nolan GP, Bendall SC, Fantl WJ, Blau HM.

Nat Cell Biol. 2017 May;19(5):558-567. doi: 10.1038/ncb3507. Epub 2017 Apr 17. Erratum in: Nat Cell Biol. 2018 Mar 5;:.

40.

The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.

Savino AM, Sarno J, Trentin L, Vieri M, Fazio G, Bardini M, Bugarin C, Fossati G, Davis KL, Gaipa G, Izraeli S, Meyer LH, Nolan GP, Biondi A, Te Kronnie G, Palmi C, Cazzaniga G.

Leukemia. 2017 Nov;31(11):2365-2375. doi: 10.1038/leu.2017.93. Epub 2017 Mar 23.

PMID:
28331226
41.

Effect of Combination Vaccines on Hepatitis B Vaccine Compliance in Children in the United States.

Kurosky SK, Davis KL, Galindo CM.

Pediatr Infect Dis J. 2017 Jul;36(7):e189-e196. doi: 10.1097/INF.0000000000001548.

PMID:
28106622
42.

Localized cortical chronic traumatic encephalopathy pathology after single, severe axonal injury in human brain.

Shively SB, Edgerton SL, Iacono D, Purohit DP, Qu BX, Haroutunian V, Davis KL, Diaz-Arrastia R, Perl DP.

Acta Neuropathol. 2017 Mar;133(3):353-366. doi: 10.1007/s00401-016-1649-7. Epub 2016 Nov 24.

43.

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.

Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, Antaki D, Shetty A, Holmans PA, Pinto D, Gujral M, Brandler WM, Malhotra D, Wang Z, Fajarado KVF, Maile MS, Ripke S, Agartz I, Albus M, Alexander M, Amin F, Atkins J, Bacanu SA, Belliveau RA Jr, Bergen SE, Bertalan M, Bevilacqua E, Bigdeli TB, Black DW, Bruggeman R, Buccola NG, Buckner RL, Bulik-Sullivan B, Byerley W, Cahn W, Cai G, Cairns MJ, Campion D, Cantor RM, Carr VJ, Carrera N, Catts SV, Chambert KD, Cheng W, Cloninger CR, Cohen D, Cormican P, Craddock N, Crespo-Facorro B, Crowley JJ, Curtis D, Davidson M, Davis KL, Degenhardt F, Del Favero J, DeLisi LE, Dikeos D, Dinan T, Djurovic S, Donohoe G, Drapeau E, Duan J, Dudbridge F, Eichhammer P, Eriksson J, Escott-Price V, Essioux L, Fanous AH, Farh KH, Farrell MS, Frank J, Franke L, Freedman R, Freimer NB, Friedman JI, Forstner AJ, Fromer M, Genovese G, Georgieva L, Gershon ES, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, Gratten J, de Haan L, Hamshere ML, Hansen M, Hansen T, Haroutunian V, Hartmann AM, Henskens FA, Herms S, Hirschhorn JN, Hoffmann P, Hofman A, Huang H, Ikeda M, Joa I, Kähler AK, Kahn RS, Kalaydjieva L, Karjalainen J, Kavanagh D, Keller MC, Kelly BJ, Kennedy JL, Kim Y, Knowles JA, Konte B, Laurent C, Lee P, Lee SH, Legge SE, Lerer B, Levy DL, Liang KY, Lieberman J, Lönnqvist J, Loughland CM, Magnusson PKE, Maher BS, Maier W, Mallet J, Mattheisen M, Mattingsdal M, McCarley RW, McDonald C, McIntosh AM, Meier S, Meijer CJ, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mokrab Y, Morris DW, Müller-Myhsok B, Murphy KC, Murray RM, Myin-Germeys I, Nenadic I, Nertney DA, Nestadt G, Nicodemus KK, Nisenbaum L, Nordin A, O'Callaghan E, O'Dushlaine C, Oh SY, Olincy A, Olsen L, O'Neill FA, Van Os J, Pantelis C, Papadimitriou GN, Parkhomenko E, Pato MT, Paunio T; Psychosis Endophenotypes International Consortium, Perkins DO, Pers TH, Pietiläinen O, Pimm J, Pocklington AJ, Powell J, Price A, Pulver AE, Purcell SM, Quested D, Rasmussen HB, Reichenberg A, Reimers MA, Richards AL, Roffman JL, Roussos P, Ruderfer DM, Salomaa V, Sanders AR, Savitz A, Schall U, Schulze TG, Schwab SG, Scolnick EM, Scott RJ, Seidman LJ, Shi J, Silverman JM, Smoller JW, Söderman E, Spencer CCA, Stahl EA, Strengman E, Strohmaier J, Stroup TS, Suvisaari J, Svrakic DM, Szatkiewicz JP, Thirumalai S, Tooney PA, Veijola J, Visscher PM, Waddington J, Walsh D, Webb BT, Weiser M, Wildenauer DB, Williams NM, Williams S, Witt SH, Wolen AR, Wormley BK, Wray NR, Wu JQ, Zai CC, Adolfsson R, Andreassen OA, Blackwood DHR, Bramon E, Buxbaum JD, Cichon S, Collier DA, Corvin A, Daly MJ, Darvasi A, Domenici E, Esko T, Gejman PV, Gill M, Gurling H, Hultman CM, Iwata N, Jablensky AV, Jönsson EG, Kendler KS, Kirov G, Knight J, Levinson DF, Li QS, McCarroll SA, McQuillin A, Moran JL, Mowry BJ, Nöthen MM, Ophoff RA, Owen MJ, Palotie A, Pato CN, Petryshen TL, Posthuma D, Rietschel M, Riley BP, Rujescu D, Sklar P, St Clair D, Walters JTR, Werge T, Sullivan PF, O'Donovan MC, Scherer SW, Neale BM, Sebat J; CNV and Schizophrenia Working Groups of the Psychiatric Genomics Consortium.

Nat Genet. 2017 Jan;49(1):27-35. doi: 10.1038/ng.3725. Epub 2016 Nov 21. Erratum in: Nat Genet. 2017 Mar 30;49(4):651. Nat Genet. 2017 Sep 27;49(10 ):1558.

44.

Validation of the Intensive Care Unit Early Warning Dashboard: Quality Improvement Utilizing a Retrospective Case-Control Evaluation.

Kavanaugh MJ, So JD, Park PJ, Davis KL.

Telemed J E Health. 2017 Feb;23(2):88-95. doi: 10.1089/tmj.2016.0073. Epub 2016 Jul 8.

PMID:
27391204
45.

Automated mapping of phenotype space with single-cell data.

Samusik N, Good Z, Spitzer MH, Davis KL, Nolan GP.

Nat Methods. 2016 Jun;13(6):493-6. doi: 10.1038/nmeth.3863. Epub 2016 May 16.

46.

The use of HeRo catheter in catheter-dependent dialysis patients with superior vena cava occlusion.

Davis KL, Gurley JC, Davenport DL, Xenos ES.

J Vasc Access. 2016 Mar-Apr;17(2):138-42. doi: 10.5301/jva.5000493. Epub 2016 Jan 20.

PMID:
26797902
47.

Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with Ruxolitinib.

Davis KL, Côté I, Kaye JA, Mendelson E, Gao H, Perez Ronco J.

Adv Hematol. 2015;2015:848473. doi: 10.1155/2015/848473. Epub 2015 Nov 9.

48.

Completion and compliance of childhood vaccinations in the United States.

Kurosky SK, Davis KL, Krishnarajah G.

Vaccine. 2016 Jan 12;34(3):387-94. doi: 10.1016/j.vaccine.2015.11.011. Epub 2015 Nov 18.

49.

Integrating health promotion and occupational safety and health in manufacturing worksites: Perspectives of leaders in small-to-medium sized businesses.

Nelson CC, Allen JD, McLellan D, Pronk N, Davis KL.

Work. 2015;52(1):169-76. doi: 10.3233/WOR-152038.

PMID:
26410231
50.

Organizational Characteristics Influence Implementation of Worksite Health Protection and Promotion Programs: Evidence From Smaller Businesses.

McLellan DL, Cabán-Martinez AJ, Nelson CC, Pronk NP, Katz JN, Allen JD, Davis KL, Wagner GR, Sorensen G.

J Occup Environ Med. 2015 Sep;57(9):1009-16. doi: 10.1097/JOM.0000000000000517.

Supplemental Content

Loading ...
Support Center